RecruitingPhase 2NCT05816603

Transcranial Direct Current Stimulation for Post-stroke Fatigue

Home-based Post-stroke Fatigue Treatment Using Transcranial Direct Current Stimulation (tDCS)


Sponsor

Weill Medical College of Cornell University

Enrollment

24 participants

Start Date

May 23, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The investigators hypothesize that delivery of anodal tDCS to the left frontal head region will reduce fatigue severity following stroke.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Real Soterix Mini-CT tDCS stimulator and a medical device called Sham Soterix Mini-CT tDCS stimulator for people with fatigue and stroke rehabilitaion. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEReal Soterix Mini-CT tDCS stimulator

Real transcranial electrical stimulation at 2mA intensity will be delivered to the left dorsolateral prefrontal cortex, 20 minutes/day, 14-day duration.

DEVICESham Soterix Mini-CT tDCS stimulator

Sham stimulation to the left dorsolateral prefrontal cortex, 20 minutes/day, 14-day duration. The device will ramp up and ramp down current delivery from 0 mA -2 mA - 0 mA over 30 seconds at the start of the 20-minute protocol with no active stimulation until the end of the 20 minutes, at which time the 30-second ramp up/ramp down will be repeated.


Locations(1)

Weill Cornell Medicine, 525 E. 68th St, Baker Pavilion, F-2106

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05816603


Related Trials